Get started
Author

Zvi Ioav Cabantchik

Observed names: Z CABANTCHIK, Z I Cabantchik, Z IOAV CABANTCHIK, Z Ioav Cabantchik, Z. I. Cabantchik, Z. IOAV CABANTCHIK, Z. Ioav CABANTCHIK, Z. Ioav Cabantchik, Z.I Cabantchik, Z.I. Cabantchik, Z.Ioav Cabantchik, Zvi I. Cabantchik
Observed institutions: Novartis (Switzerland), Hôpital Necker-Enfants Malades, National Institutes of Health, Inserm, Utrecht University, Hebrew University of Jerusalem, Université de Lille, Mahidol University, Hadassah Medical Center, Shaare Zedek Medical Center, Bikur Cholim Hospital, University Medical Center Utrecht, Centre Hospitalier Universitaire de Lille, Institut Necker Enfants Malades, Institute of Life Sciences, Hôpital Pontchaillou, National Institute of Allergy and Infectious Diseases, Institute of Life Sciences, Novartis Institutes for BioMedical Research, Lady Davis Institute for Medical Research
OpenAlex ID: A5065072598
The labile iron pool: characterization, measurement, and participation in cellular processes1 1This article is part of a series of reviews on “Iron and Cellular Redox Status.” The full list of papers may be found on the homepage of the journal.
2002 · Or Kakhlon, Z.Ioav Cabantchik · Free Radical Biology and Medicine · 850
Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease
2013 · David Devos, Caroline Moreau, et al. · Antioxidants and Redox Signaling · 641
Labile plasma iron in iron overload: redox activity and susceptibility to chelation
2003 · Breno P. Esposito, William Breuer, et al. · Blood · 478
PDF
Selective iron chelation in Friedreich ataxia: biologic and clinical implications
2007 · Nathalie Boddaert, Kim Hanh Le Quan Sang, et al. · Blood · 418
Fluorescence Analysis of the Labile Iron Pool of Mammalian Cells
1997 · Silvina Epsztejn, Or Kakhlon, et al. · Analytical Biochemistry · 398
Iron Acquired from Transferrin by K562 Cells Is Delivered into a Cytoplasmic Pool of Chelatable Iron(II)
1995 · William Breuer, Silvina Epsztejn, et al. · Journal of Biological Chemistry · 326
Ineffective erythropoiesis in β-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin
2007 · Sara Gardenghi, Maria F. Marongiu, et al. · Blood · 313
Labile iron in cells and body fluids: physiology, pathology, and pharmacology
2014 · Zvi Ioav Cabantchik · Frontiers in Pharmacology · 312
PDF
LPI-labile plasma iron in iron overload
2005 · Z CABANTCHIK, W BREUER, et al. · Best Practice & Research Clinical Haematology · 293
The importance of non-transferrin bound iron in disorders of iron metabolism
2000 · W Breuer, C Hershko, et al. · Transfusion Science · 271
Intracellular labile iron pools as direct targets of iron chelators: a fluorescence study of chelator action in living cells
2005 · Hava Glickstein, Rinat Ben El, et al. · Blood · 253
PDF
A Review of Fluorescence Methods for Assessing Labile Iron in Cells and Biological Fluids
2002 · Breno P. Espósito, Silvina Epsztejn, et al. · Analytical Biochemistry · 246
H-Ferritin Subunit Overexpression in Erythroid Cells Reduces the Oxidative Stress Response and Induces Multidrug Resistance Properties
1999 · Silvina Epsztejn, Hava Glickstein, et al. · Blood · 208
Action of chelators in iron-loaded cardiac cells: accessibility to intracellular labile iron and functional consequences
2006 · Hava Glickstein, Rinat Ben El, et al. · Blood · 200
PDF
Transferrin therapy ameliorates disease in β-thalassemic mice
2010 · Huihui Li, Anne C Rybicki, et al. · Nature Medicine · 193
Intracellular labile iron
2007 · William Breuer, Maya Shvartsman, et al. · The International Journal of Biochemistry & Cell Biology · 180
Characterization of permeation pathways in the plasma membrane of human erythrocytes infected with early stages of Plasmodium falciparum: Association with parasite development
1985 · S. Kutner, W. V. Breuer, et al. · Journal of Cellular Physiology · 170
Redistribution of accumulated cell iron: a modality of chelation with therapeutic implications
2007 · Yang-Sung Sohn, William Breuer, et al. · Blood · 168
Desferrioxamine-chelatable iron, a component of serum non–transferrin-bound iron, used for assessing chelation therapy
2001 · William Breuer, Marieke J. J. Ermers, et al. · Blood · 156
PDF
The Cellular Labile Iron Pool and Intracellular Ferritin in K562 Cells
1999 · Abraham M. Konijn, Hava Glickstein, et al. · Blood · 155
Redox active plasma iron in C282Y/C282Y hemochromatosis
2005 · Caroline Le Lan, Olivier Loréal, et al. · Blood · 151
PDF
ICL670A: a new synthetic oral chelator: evaluation in hypertransfused rats with selective radioiron probes of hepatocellular and reticuloendothelial iron stores and in iron-loaded rat heart cells in culture
2001 · Chaim Hershko, Abraham M. Konijn, et al. · Blood · 151
Facile transfer of [2Fe-2S] clusters from the diabetes drug target mitoNEET to an apo-acceptor protein
2011 · John A. Zuris, Yael Harir, et al. · Proceedings of the National Academy of Sciences · 142
Conservative iron chelation for neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis
2020 · The FAIRPARK-II and FAIRALS-II studygroups, David Devos, et al. · Journal of Neural Transmission · 135
Labile plasma iron (LPI) as an indicator of chelatable plasma redox activity in iron-overloaded β-thalassemia/HbE patients treated with an oral chelator
2004 · Pensri Pootrakul, William Breuer, et al. · Blood · 133
PDF
Works count: 87
Citation count: 9,866
H-index: 51
I10-index: 72
Year
Topic
Type